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prostanoid receptor agonists; electrophysiology; motile activity; bone resorption PROSTAGLANDIN (PG)E 2 is an important regulator of many physiological and pathological processes of bone metabolism and is generally believed to modulate both bone formation and bone resorption (30) . Yoshida et al. (39) found that PGE 2 acts on osteoblast precursors, inducing osteoblasts for bone formation, but also acts on mature osteoblasts, inducing osteoclasts for bone resorption. PGE 2 exerts its effects through specific receptors that consist of four subtypes designated EP1, EP2, EP3, and EP4 (25) , and osteoblasts have been shown to express several of these PGE 2 receptor subtypes (32, 33) . Recent studies using EP receptorknockout animals and selective EP receptor agonists demonstrated that EP4 and/or EP2 mediate both anabolic (37, 39) and catabolic (24, 33) actions of PGE 2 .
Evidence is mounting that PGE 2 also has a direct effect on osteoclasts and negatively regulates their bone-resorbing activity (5, 6, 10, 14, 22) . Chambers and coworkers (5, 6, 10) demonstrated that PGE 2 causes cytoplasmic retraction and reduction of motility (i.e., movement of the peripheral cell membrane lamellipodia) in isolated osteoclasts, thereby inhibiting bone resorption. Kaji et al. (14) reported that PGE 2 inhibits bone resorption in the absence of osteoblasts but stimulates bone resorption in the presence of osteoblasts. A study using highly purified rabbit osteoclasts showed that osteoclasts express EP4 and EP2 receptors and that both receptors participate in the inhibitory effect of PGE 2 on osteoclast activity (22) .
Several types of ion channels have been identified in osteoclasts, and their physiological roles in the activities of osteoclasts have been reported (19) . Recently, we demonstrated (15) that membrane depolarization induced by exposing osteoclasts to high-K ϩ solution decreases intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) and causes cytoplasmic retraction and reduction of motility. This result demonstrates the importance of cell membrane potential for controlling [Ca 2ϩ ] i and morphology in osteoclasts. Because membrane potential is regulated by the activities of several ion channel types expressed in osteoclasts, activation and deactivation of these channels is likely to determine osteoclast morphology. Several agents that modulate bone resorption have also been shown to modulate ion channels in osteoclasts (20, 27, 29) . Therefore, to understand the role of PGE 2 in osteoclast physiology and pathology, an understanding of its actions on ion channels is desirable. There is no previous report on PGE 2 -mediated effects on osteoclast ion channels to our knowledge.
In the present study, we applied the whole cell patch-clamp technique to isolated rat osteoclasts and examined the effects of PGE 2 on ion channel activity and the role of these channels in PGE 2 -induced morphological changes. We found that PGE 2 acts directly on rat osteoclasts and stimulates outwardly rectifying Cl Ϫ channels via a cAMP-dependent mechanism through EP2 and EP4 receptors. This pathway contributes to reduction of cell area and loss of osteoclast motility.
MATERIALS AND METHODS
Osteoclast preparation. All procedures involving animals were approved by the Council on Animal Care at the Fukuoka Dental College. Osteoclasts were obtained from the femur and tibia of neonatal Wistar rats (1-2 days old). Rats were anesthetized with diethyl ether and killed by decapitation. The femur and tibia were separated from adhering soft tissues. The bones were finely chopped into culture medium [␣-minimum essential medium (␣-MEM); Invitrogen, Grand Island, NY] containing 15% heat-inactivated fetal bovine serum (FBS; Invitrogen), 100 U/ml penicillin G, 0.15 mg/ml streptomycin sulfate, and 20 mM NaHCO 3. The resulting suspension was gently agitated with a bore-tipped pipette to hasten dissociation of osteoclasts from the bone surface. This suspension was seeded on glass coverslips (5 mm ϫ 5 mm) and incubated in the culture medium with 5% CO 2-95% air at 37°C. After 30 min, the coverslips were gently washed with fresh culture medium to remove nonadherent cells and debris. Adherent cells were reincubated in fresh culture medium at 37°C. We obtained a preparation of mixed bone cells by this procedure. As we reported previously (15) , two types of multinucleated cells adhering to glass coverslips can be distinguished by their shape and their ability to form a distinctive organization of F-actin, called "actin rings." One cell type had a flat, round shape and displayed an actin ring when stained with rhodamine-conjugated phalloidin after cell fixation with formaldehyde (15) . The other cell type showed a more bulgy shape with serrated edges and did not display actin rings. For electrophysiological and morphological analysis, we selected only multinucleated cells having a bulgy shape with serrated edges (40-to 90-m diameter). Identity of the selected cells was confirmed by tartrate-resistant acid phosphatase (TRAP) stain at the end of the electrophysiological recordings, as described previously (27) . In all morphological and some electrophysiological experiments, we used a pure osteoclast preparation that was obtained by the following procedure. The preparation of mixed bone cells, obtained as described above, was placed in a 35-mm tissue culture dish filled with culture medium. The culture dish was mounted on an inverted microscope, and cells with one or two nuclei were removed manually from the coverslips by means of a cell scraper (made of a thin silicone rubber) with a micromanipulator (MMW-23; Narishige Scientific Instrument Laboratory, Tokyo, Japan). Multinucleated cells remaining on the coverslip were positively stained by TRAP. All experiments were done within 8 h after cell isolation.
Electrophysiological measurements. The coverslip with adherent cells was placed in a recording chamber (volume 1 ml) mounted on an inverted microscope (TE 300; Nikon, Tokyo, Japan) and continuously superfused (1 ml/min) with standard extracellular solution (HEPESbuffered solution) containing (in mM) 134 NaCl, 6 KCl, 10 glucose, 0.5 MgCl 2, 1.25 CaCl2, and 10 HEPES, adjusted to pH 7.3 with Tris. In some preliminary experiments a bicarbonate-buffered solution was used, which was prepared by replacing HEPES in the standard extracellular solution with 14.5 mM NaHCO 3. This solution was gassed with 5% CO 2-95% O2 and had a pH of 7.3. The patch pipette solution for recording of membrane potential and whole cell currents (shown in Fig. 1A ) contained (in mM) 140 KCl, 3 MgCl 2, 2 ATP Fig. 1 . Effects of prostaglandin (PG)E2 on whole cell currents in rat osteoclasts. A: whole cell currents recorded from a cell bathed in standard extracellular solution (HEPES-buffered solution) with the patch pipette solution containing KCl. a: Effect of 100 nM PGE2 on the whole cell currents evoked by voltage steps. Membrane potential was held at Ϫ50 mV, and square pulses (300-ms duration) were applied from Ϫ120 to 90 mV in 30-mV increments. Currents were recorded before (control) and 5 min after application of PGE2. Dashed line indicates zero-current level. b: Current-voltage (I-V) relationships recorded by voltage ramps (2-s duration) from Ϫ120 to 100 mV from a holding potential of Ϫ50 mV. The I-V relationships obtained before (control), 4 min after application of PGE2 (100 nM PGE2), and 5 min after cumulative application of 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS; 100 nM PGE2 ϩ 100 M DIDS) to the extracellular solution are superimposed. Recordings in a and b were obtained from the same cell. Osmolarity of all solutions was measured with a freezing-point depression osmometer (Osmometer Automatic; Knauer, Berlin, Germany) and adjusted to 290 -300 mosM with mannitol. Hypotonic solution (210 mosM) was made by reducing NaCl concentration in the extracellular K ϩ -free solution to 100 mM. Low-NaCl (100 mM) isotonic solution (290 mosM) was prepared by addition of 80 mM mannitol to the hypotonic solution for control experiments. In some experiments, 100 mM NaCl in the hypotonic solution was replaced entirely with the same concentration of NaI, NaBr, or sodium gluconate.
Membrane potential and currents were recorded with the whole cell configuration patch-clamp technique (12) with an amplifier (Axopatch 200A; Axon Instruments, Foster City, CA). Currents were filtered at 1 kHz and digitized at a sampling frequency of 2-5 kHz. Data acquisition and analysis were performed with pCLAMP 8.0 software (Axon Instruments). All electrophysiological experiments were performed at 26 -27°C.
Patch pipettes were prepared with a pipette puller (P-97; Sutter Instrument, Novato, CA), and their tips were heat polished with a microforge (MF83; Narishige Scientific Instrument Laboratory). Values of electrode resistance of the patch pipette filled with the patch pipette solution were in the range of 2.5-5 M⍀. Series resistance (60 -80%) was compensated to minimize the clamp speed. An AgAgCl reference electrode was connected to the extracellular solution through a 3 M KCl-agar salt bridge to minimize changes in liquid junction potentials. Membrane potential was then corrected for liquid junction potentials as previously described (17) . The zero-current potential before formation of the gigaseal was set to 0 mV.
Morphological analysis. The pure osteoclast preparation was placed in a plastic petri dish filled with ␣-MEM containing 5 mM HEPES, adjusted to pH 7.3 with Tris. In some preliminary experiments, we used ␣-MEM containing 14.5 mM NaHCO3, equilibrated with 5% CO2-95% O2 to maintain a pH of 7.3, as the bath solution. In these experiments, FBS was omitted from ␣-MEM (serum-free culture medium) to avoid any influence by this ingredient. The petri dish was then placed in a temperature-controlled incubation chamber (Tokai Hit, Japan) mounted on an inverted phase-contrast microscope (TMS; Nikon) and incubated at 37°C. The microscope was connected through a charge-coupled device (CCD) camera (CS8310; Tokyo Electronic Industry, Tokyo, Japan) to a time-lapse video recorder (KV 7168; Toshiba, Tokyo, Japan). Osteoclasts were preincubated with serum-free culture medium for ϳ1 h before the recordings were started. PGE2 or other test agents were added directly to the serumfree culture medium. Images of osteoclasts were digitized at intervals of 2 min and stored in a Macintosh G4 computer (Apple). Image analysis software (NIH Image, version 1.62) was used for measurement of osteoclast planar area. The planar area A(t) of an osteoclast at time t (in minutes) was quantitated by tracing the outlines of individual cells and normalized to 100% at the beginning of the recording. Osteoclasts continuously move their membrane periphery by protracting and retracting lamellipodia. This phenomenon has been described in terms of motility (1), and we assessed this motility on the basis of the method originally described by Alam et al. (1) . An outline of each cell obtained at time t was overlaid on the subsequent outline at time t ϩ 2. The nonoverlapping area (⌬A) was measured with NIH Image and expressed relative to A(t). The change in ⌬A/A(t) was used as an index of cell motility.
Drugs. PGE2 receptor agonists, ONO-DI-004 (EP1 agonist), ONO-AE1-259 (EP2 agonist), ONO-AE-248 (EP3 agonist), and ONO-AE1-329 (EP4 agonist), were kindly supplied by Ono Pharmaceutical (Osaka, Japan). PGE 2, forskolin, guanosine 5Ј-O-(2-thiodiphosphate) (GDP␤S) trilithium salt, dibutyryl adenosine 3Ј,5Ј-cyclic monophosphate (DBcAMP), phorbol 12-myristate 13-acetate (PMA), Rp-adenosine-3Ј,5Ј-cyclic monophosphorothioate (Rp-cAMPS), and tamoxifen were purchased from Sigma (St. Louis, MO).
, ionomycin, and 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) were obtained from Calbiochem (La Jolla, CA). The above drugs were dissolved in dimethyl sulfoxide (DMSO; Sigma) and later diluted with extracellular solutions or the patch pipette solutions to reach final concentration, which resulted in a final DMSO concentration of Ͻ0.05%. 4,4Ј-Diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS; Sigma) was dissolved directly in the extracellular solution. All other chemicals were obtained from Sigma.
Statistical analysis. Data are expressed as means Ϯ SE for n observations. Statistical differences were analyzed with Student's t-test, and a value of P Ͻ 0.05 was considered to be significant.
RESULTS

Stimulatory effects of PGE 2 on outward rectifier Cl
Ϫ current in rat osteoclasts. Figure 1Aa shows the effect of PGE 2 on whole cell currents evoked by voltage step pulses (from Ϫ120 to 90 mV in 30-mV increments) applied from a holding potential of Ϫ50 mV. In the standard extracellular solution (HEPES-buffered solution), hyperpolarizing pulses elicited an inwardly rectifying current due to inward rectifier K ϩ channels, whereas depolarizing pulses elicited a much smaller outwardly rectifying current (Fig. 1Aa) , as described previously (27, 29) . Application of PGE 2 (100 nM) to the bath for 5 min augmented the outward current, whereas the inward current was not altered. Figure 1Ab shows the current-voltage (I-V) relationships in the absence (control) and presence of either PGE 2 (100 nM) alone or PGE 2 plus the Cl Ϫ channel blocker DIDS (100 M), a stilbene derivative, with a voltage ramp from Ϫ120 to 100 mV. The I-V curves in the presence and absence of PGE 2 crossed near 0 mV, right at the calculated equilibrium potential for Cl Ϫ (0 mV) but far from that for K ϩ (Ϫ79 mV) under our experimental conditions. Cumulative application of DIDS inhibited the outward current induced by PGE 2 without visible effect on the inward current ( Fig. 1Ab ; 100 nM PGE 2 ϩ 100 M DIDS). The effects of PGE 2 on whole cell currents were also examined in bicarbonate-buffered extracellular solution, and the same results were observed: PGE 2 (100 nM) augmented the outward current with minor effect on the inward current, and cumulative application of DIDS abolished the augmentation of the outward current (Fig.  1B) . Therefore, we assumed that HEPES-buffered solution is an adequate experimental condition to elucidate the effects of PGE 2 on osteoclast ion channels, and all subsequent electrophysiological experiments were performed with HEPES-buffered solutions. When K ϩ in the extracellular and pipette solutions was replaced by Na ϩ or Cs fying currents with slow inactivation kinetics at strong positive potentials (Fig. 2Aa) . Figure 2Ab shows outwardly rectifying current elicited by a voltage ramp from Ϫ70 to 100 mV and the currents obtained before application, during application, and after removal of PGE 2 . The reversal potential of the PGE 2 -stimulated current was about Ϫ18 mV, very close to the predicted equilibrium potential for Cl
were 143.5 and 53.5 mM, respectively]. The stimulatory effect reached a maximum within 5 min after application of PGE 2 and was sustained for Ͼ10 min with only slight current reduction. Removal of PGE 2 abolished the stimulatory effect. PGE 2 stimulated current at concentrations of 10 nM and above. The relationship between PGE 2 concentration and current augmentation is shown in Fig. 2Ac .
Similar stimulatory effects of PGE 2 on Cl Ϫ current were also recorded from a pure osteoclast preparation (osteoclasts cultured without nonosteoclastic cells). Amplitudes of current in the presence of 1 M PGE 2 at a membrane potential of 80 mV were the same in osteoclasts prepared from pure osteoclast or mixed-cell preparations [23.5 Ϯ 5.8 pA/pF (n ϭ 8) for pure osteoclast preparations and 25.7 Ϯ 4.2 pA/pF (n ϭ 12) for mixed-cell preparations]. This indicates the presence of a direct stimulatory pathway for PGE 2 on outwardly rectifying current in osteoclasts.
The (Fig. 3) . Values for the relative mem- brane permeability of each anion against Cl Ϫ (P X /P Cl ) were estimated from the reversal potential changes by the following equation derived from the Goldman-Hodgkin-Katz equation: Replacement of Cl Ϫ by I Ϫ shifted the reversal potential toward more negative potentials (Fig. 3A, top) . In contrast, replacement of Cl Ϫ by gluconate Ϫ , but not by Br Ϫ , shifted the reversal potential in the positive direction (Fig. 3A, bottom) . The estimated P X /P Cl was 1.50 Ϯ 0.09 (n ϭ 4) for I Ϫ , 1.09 Ϯ 0.09 (n ϭ 5) for Br Ϫ , and 0.29 Ϯ 0.05 (n ϭ 4) for gluconate Ϫ (Fig. 3B) , giving an anion permeability sequence of
Sensitivity of PGE 2 -stimulated Cl
Ϫ current to Cl Ϫ channel blockers. To examine the effects of the Cl Ϫ channel blockers DIDS, 4-acetamido-4Ј-isothiocyanostilbene-2,2Ј-disulfonic acid (SITS), and NPPB on the PGE 2 -stimulated Cl Ϫ current (Fig. 4,  A and B) , these blockers were applied to the bath after the current was maximally stimulated by PGE 2 . DIDS (30 M) reversibly inhibited the PGE 2 -induced Cl Ϫ current in a voltagedependent manner, being more effective on the outward current than on the inward current ( Fig. 4A ; 44 Ϯ 5% inhibition at 70 mV vs. 20 Ϯ 6% inhibition at Ϫ70 mV; n ϭ 5). The following application of 100 M DIDS caused further suppression of the PGE 2 -stimulated current. Another stilbene derivative, SITS, also inhibited the PGE 2 -induced Cl Ϫ current in a voltage-dependent manner (data not shown). NPPB (30 M), an arylaminobenzoate, also inhibited the PGE 2 -induced Cl Ϫ current and affected outward and inward currents equally ( Fig. 4B ; 60 Ϯ 4% inhibition at 70 mV vs. 55 Ϯ 6% inhibition at Ϫ70 mV; n ϭ 5). Figure 4C shows the effect of tamoxifen, an inhibitor of the swelling-activated Cl Ϫ channels (26), on the PGE 2 -stimulated Cl Ϫ current. Application of tamoxifen (10 M) caused only weak inhibition of the PGE 2 -stimulated Cl Ϫ current. The following application of a higher concentration of tamoxifen (100 M) further inhibited the PGE 2 -stimulated Cl Ϫ current in a voltage-independent manner ( Fig. 4C ; 89 Ϯ 8% inhibition at 70 mV vs. 82 Ϯ 6% inhibition at Ϫ70 mV; n ϭ 5).
Effects of PGE 2 on Cl Ϫ current under hyposmotic conditions. Outwardly rectifying Cl
Ϫ current has also been elicited by reduction of extracellular osmolarity in rabbit osteoclasts (17) and mice osteoclasts (31) . Therefore, we examined the effects of osmotic changes on the PGE 2 -stimulated Cl Ϫ current (Fig. 4D) . When extracellular solution was changed from isotonic (290 mosM) to hypotonic solution (210 mosM), outwardly rectifying current was augmented. The activation of this current reached a maximum within 10 min after perfusion with hypotonic solution ( Fig. 4D; Hypo) . Addition of PGE 2 (1 M) did not further enhance this current (Hypo, 22.5 Ϯ 6.0 pA/pF at 70 mV; HypoϩPGE 2 , 23.7 Ϯ 5.8 pA/pF at 70 mV; n ϭ 3). The hyposmotically induced current was inhibited by DIDS (100 M), NPPB (100 M), and tamoxifen (100 M), and the difference currents (control current Ϫ current in presence of drug) showed reversal potentials of Ϫ17 Ϯ 2 (n ϭ 3), Ϫ15 Ϯ 3 (n ϭ 3), and Ϫ14 Ϯ 3 (n ϭ 3) mV, respectively. The estimated P X /P Cl of the hyposmotically induced current was 1.66 Ϯ 0.11 (n ϭ 5) for I Ϫ , 1.03 Ϯ 0.05 (n ϭ 3) for Br Ϫ , and 0.23 Ϯ 0.08 (n ϭ 3) for gluconate Ϫ , showing the same anion permeability sequence as the current stimulated by PGE 2 (Fig. 3B) .
Effect of PGE 2 on osteoclast membrane potential. Because activation of Cl
Ϫ channels in osteoclasts causes membrane depolarization (17), we examined the effect of PGE 2 on the Fig. 3 . Anion permeability of the current stimulated by PGE2. A: I-V relationships of the current stimulated by PGE2 in Cl Ϫ -substituted solutions. Voltage ramps (2 s) from Ϫ70 to 100 mV (holding potential Ϫ50 mV) were applied. NaCl (140 mM) in the extracellular solution was replaced by an equimolar amount of NaI (I Ϫ , top), NaBr, or sodium gluconate (Br Ϫ or gluconate Ϫ , bottom). B: permeability ratios of various anions relative to Cl Ϫ (PX/PCl). A value of PX/PCl for each anion was calculated from the shift in reversal potential caused by anion replacement using Eq. 1 (see RESULTS). Numbers of cells studied are indicated in parentheses. membrane potential of osteoclasts bathed in standard extracellular solution. Seven of ten cells examined possessed a resting membrane potential between Ϫ65 and Ϫ73 mV (Ϫ68 Ϯ 2 mV; n ϭ 7). Three cells showed a resting potential of Ϫ5 to Ϫ38 mV. In cells possessing membrane potential of around Ϫ70 mV, application of PGE 2 (1 M) produced a long-lasting depolarization to 0 Ϯ 3 mV (n ϭ 4) with a latency of 1-2 min. Simultaneous application of DIDS (100 M) suppressed the PGE 2 -induced membrane depolarization (n ϭ 4).
Receptor subtypes and intracellular signal transduction pathways involved in PGE 2 -induced stimulation of Cl
Ϫ current. To determine the PGE 2 receptor subtypes (EPs) involved in the PGE 2 stimulation of Cl Ϫ current, the stimulatory effects of EP1, EP2, EP3, and EP4 receptor agonists on Cl Ϫ current were examined. Figure 5A shows dose-response relationships between amplitude of outwardly rectifying current recorded at 80 mV and concentration of various EP agonists. The EP2 agonist ONO-AE1-259 stimulated the outwardly rectifying current in a concentration-dependent manner (Fig. 5A) . The stimulatory effect was comparable to that of PGE 2 . The EP4 agonist ONO-AE1-329 also stimulated this current (Fig. 5A ), but the maximal effect was much smaller than that of PGE 2 In this experiment low-NaCl (100 mM) isotonic solution was used for control. I-V relationships were obtained by voltage ramps (2 s) from Ϫ70 to 100 mV (holding potential Ϫ50 mV).
inhibition at 70 mV vs. 28 Ϯ 5% inhibition at Ϫ70 mV; n ϭ 3). Thus electrophysiological and pharmacological properties of currents induced by ONO-AE1-259 and ONO-AE1-329 were very similar to those of currents induced by PGE 2 . On the other hand, no significant stimulatory effects on Cl Ϫ current were observed with EP1 and EP3 agonists ONO-DI-004 and ONO-AE-248 (Fig. 5A) . PGE 2 , via EP2 and EP4 subtypes, is known to stimulate adenylate cyclase and increase intracellular cAMP levels (25) . Extracellular application of forskolin (10 and 30 M), an activator of adenylate cyclase, reversibly augmented the outwardly rectifying current in a concentration-dependent manner (Fig. 5Ba) . DIDS (30 M) and NPPB (30 M) reversibly suppressed the forskolin (30 M)-induced current in voltagedependent (52 Ϯ 4% inhibition at 70 mV vs. 19 Ϯ 3% inhibition at Ϫ70 mV; n ϭ 5) and -independent (59 Ϯ 5% inhibition at 70 mV vs. 56 Ϯ 4% inhibition at Ϫ70 mV; n ϭ 4) manners, respectively. The estimated P X /P Cl values of the forskolin (30 M)-induced current were 1.45 Ϯ 0.05 (n ϭ 5) for I Ϫ , 1.01 Ϯ 0.02 (n ϭ 3) for Br Ϫ , and 0.28 Ϯ 0.05 (n ϭ 3) for gluconate Ϫ . DBcAMP (300 M), a membrane-permeant analog of cAMP, also stimulated the Cl Ϫ current with properties similar to those of the PGE 2 -and forskolin-induced currents, such as the voltage dependence and independence of block by DIDS and NPPB and the anion permeability sequence of I Ϫ Ͼ Br Ϫ Ϸ Cl Ϫ Ͼ gluconate Ϫ (data not shown). In contrast, extracellularly applied PMA (10 nM), an activator of PKC, had no stimulatory effect on the Cl Ϫ current. Elevation of [Ca 2ϩ ] i by ionomycin (5 M) had very little effect, either. GDP␤S (1 mM) inhibited the outward rectifying current stimulated by 1 M PGE 2 , demonstrating an involvement of GTP binding proteins in the PGE 2 -mediated activation of current (Fig. 5Bb) . Rp-cAMPS (300 M) and H-89 (100 nM), inhibitors of PKA, also inhibited the stimulatory effect of PGE 2 on the outwardly rectifying current. In control experiments, these signal modulators in the absence of PGE 2 did not significantly affect outwardly rectifying current. Additionally, the stimulatory effects of ONO-AE1-259 (1 M) and ONO-AE1-329 (1 M) on the Cl Ϫ current were greatly diminished by pretreatment with GDP␤S (1 mM in the pipette solution) or RpcAMPS (300 M in the pipette solution) (data not shown).
Effects of PGE 2 and EP agonists on cell planar area and motility of isolated rat osteoclasts. To assess the action of PGE 2 on osteoclast morphology, we examined PGE 2 effects on cell planar area and motility with pure osteoclast preparations (see MATERIALS AND METHODS). The morphological changes were observed in HEPES-buffered medium to match the experimental conditions of our electrophysiological experiments. Figure  6A represents time-lapse video images of bulgy serrated osteoclasts recorded before application, during application, and after removal of 1 M PGE 2 . Although osteoclasts showed intense motility, ceaselessly protruding and retracting lamelli- Effects of guanosine 5Ј-O-2-(thiodiphosphate) (GDP␤S), Rp-adenosine 3Ј,5Ј-cyclic monophosphorothioate (Rp-cAMPS), and H-89 on the PGE2-induced stimulation of Cl Ϫ current. Data were obtained 5 min after application of 1 M PGE2 in the absence (control) or presence of the intracellular signal modulators. GDP␤S (1 mM) or Rp-cAMPS (300 M) was added to the patch pipette solution and allowed to diffuse into the cell for ϳ10 min before application of PGE2. H-89 (100 nM) was applied extracellularly for ϳ10 min before application of PGE2. *P Ͻ 0.01 vs. control. In A and B, amplitudes of the net currents were measured at a membrane potential of 80 mV and expressed as current density by normalizing to cell capacitance. Numbers of cells examined are indicated in parentheses.
podia before application of PGE 2 , a sustained decrease or increase in cell planar area did not occur. DMSO (0.05%) did not change averaged values of osteoclast planar area or motility. Application of 1 M PGE 2 produced a progressive decrease in planar area (19 Ϯ 5% inhibition at 15 min; n ϭ 5), reduced osteoclast motility (21 Ϯ 3% inhibition at 15 min; n ϭ 5) (Fig. 6B) , and resulted in a spiny appearance of the cell periphery (Fig. 6A, center) . Effects of PGE 2 on cell planar area and motility reached a maximum within 10 min after application of PGE 2 and were sustained during the application (Fig.  6B) . Removal of PGE 2 reversed both effects (Fig. 6A, right) . The effects of PGE 2 on cell planar area and motility were also examined in bicarbonate-buffered medium, and results qualitatively similar to those in HEPES-buffered medium were obtained: PGE 2 (1 M) reduced osteoclast planar area (14 Ϯ 5% inhibition at 15 min; n ϭ 4) and inhibited motility (21 Ϯ 3% inhibition at 15 min; n ϭ 4). These results suggest that PGE 2 -induced morphological changes are relevant to osteoclast physiology. Because the preparation contained only osteoclasts (pure osteoclast preparation), these results also confirm that PGE 2 acts directly on osteoclasts.
We next determined the EPs contributing to PGE 2 -induced reduction of cell planar area and motility. Effects of PGE 2 and EP agonists on osteoclast planar area and motility are summarized in Fig. 6C . The EP2 agonist ONO-AE1-259 (1 M) reduced cell planar area and motility with effects comparable to those of 1 M PGE 2 . A higher concentration of the EP4 agonist ONO-AE1-329 (10 M) also caused a decrease of cell planar area but showed no significant effect on cell motility. In contrast, neither the EP1 agonist ONO-DI-004 nor the EP3 agonist ONO-AE-248 elicited any significant changes in osteoclast planar area or motility when used in concentrations up to 10 M. 2 -induced morphological changes. Application of forskolin (10 M) reduced osteoclast planar area and motility (Fig. 7A) . DBcAMP (1 mM) also reduced cell planar area and motility. Pretreatment with Rp-cAMPS (50 M) for 30 min inhibited the PGE 2 -induced reduction of osteoclast planar area and motility (Fig. 7B) . Figure 7C summarizes the effects of PKA inhibitors on 1 M PGE 2 -induced reduction of cell planar area and motility. Pretreatment of osteoclasts with H-89 (1 M) also reduced the PGE 2 effects on cell planar area and motility.
Signal transduction pathways involved in PGE
DISCUSSION
Mechanisms of action of PGE 2 in rat osteoclasts. Osteoblasts have been reported to be the main target for PGE 2 action on bone metabolism (14, 34) . The present study shows that PGE 2 activates outwardly rectifying Cl Ϫ channels in bulgy, serrated rat osteoclasts, independent of the presence of osteoblasts or other nonosteoclastic cells. PGE 2 reduced osteoclast planar area associated with inhibition of their motility even in the absence of nonosteoclastic cells; thus actions of PGE 2 were independent of soluble factors secreted from nonosteoclastic cells. This demonstrates that PGE 2 has a direct action on osteoclasts.
PGE 2 exerts its effects through specific membrane receptors coupled to GTP-binding proteins (25) . Four subtypes of PGE 2 receptors with different intracellular signaling pathways have been identified. The EP1 subtype induces [Ca 2ϩ ] i mobilization, both EP2 and EP4 subtypes stimulate adenylate cyclase, and the EP3 subtype mainly inhibits adenylate cyclase (25) . Among specific agonists for each of the four subtypes of PGE 2 receptors, ONO-AE1-259, an EP2 agonist, was most effective in stimulating the Cl Ϫ current and reducing cell planar area and motility. Our results are most consistent with the presence of EP2 receptor on osteoclasts: 1) GDP␤S, Rp-cAMPS, and H-89 inhibit the PGE 2 -induced current, and 2) forskolin and DBcAMP mimic the PGE 2 -induced current.
ONO-AE1-329, an EP4 agonist, also had a stimulatory effect on Cl Ϫ current and caused a reduction of cell planar area, but both effects were much weaker than those of ONO-AE1-259. It thus appears that PGE 2 -induced changes in osteoclast electrophysiology and morphology are mediated predominantly by the EP2 subtype and to a lesser degree by the EP4 subtype. In contrast to our findings, Mano et al. (22) reported that direct action of PGE 2 on rabbit osteoclasts was mediated by the EP4 subtype and that EP4 mRNA was abundantly expressed in rabbit osteoclasts, whereas the other types of EP mRNAs, including EP2 mRNA, were detected only in minor amounts. Although this discrepancy may be attributed to differences in animal species, further experiments at the molecular or protein level are required to elucidate the different mechanisms of PGE 2 action in rats and rabbits.
Properties of PGE 2 -stimulated Cl Ϫ current in osteoclasts. The PGE 2 -stimulated Cl Ϫ current examined in this study was characterized by outward rectification, rapid activation, timedependent inactivation at strong depolarizing potentials (Fig.  2) , an anion permeability sequence of I Ϫ Ͼ Br Ϫ Ϸ Cl Ϫ Ͼ gluconate Ϫ (Fig. 3) , and block by DIDS, NPPB, and tamoxifen (Fig. 4, A-C) . The Cl Ϫ current stimulated by forskolin also showed characteristics similar to those of the PGE 2 -stimulated Cl Ϫ current. The electrophysiological and pharmacological properties of the PGE 2 -stimulated Cl Ϫ current examined in our study also resemble those of the current induced by hyposmotic stimulation (swelling-activated Cl Ϫ currents) demonstrated previously in a variety of cells (23, 26, 36, 38) including mouse osteoclasts (31) . In addition, any further stimulatory effect of PGE 2 on the current was abolished after currents were induced by hyposmotic solution (Fig. 4D) , indicating that PGE 2 -induced current and hyposmotically activated current share a common pathway. The presence of such a common pathway for cAMP-and swelling-activated Cl Ϫ currents has also been suggested in rat carotid body cells (4) .
It is well known that cystic fibrosis transmembrane conductance regulator (CFTR) Cl Ϫ channels are activated by a cAMPdependent pathway (13) . However, the electrophysiological properties of CFTR Cl Ϫ channels, showing a linear I-V relationship in symmetrical Cl Ϫ concentration, insensitivity to extracellular DIDS, and an anion permeability sequence of Cl Ϫ Ͼ I Ϫ (2, 7, 13), are unlike those of the PGE 2 -stimulated current demonstrated in our study. Therefore, the channel responsible for the PGE 2 -stimulated current in rat osteoclasts differs from the CFTR Cl Ϫ channel. A recent report by Diewald et al. (8) shows that CLC-7 Cl Ϫ channels expressed in Xenopus oocytes display outwardly rectifying properties similar to the Cl Ϫ current described in the present study. However, the electrophysiological and pharmacological properties of CLC-7 Cl Ϫ channels have not yet been established. Thus it is presently uncertain whether or not the Cl Ϫ current stimulated by PGE 2 is carried by CLC-7 Cl Ϫ channels.
Possible contribution of Cl
Ϫ channels to PGE 2 -induced changes in osteoclast morphology. Osteoclasts alternate between resorptive and motile states (16) , both of which are necessary for effective bone resorption. Cl Ϫ channels have been documented to play important roles in bone resorption during the resorptive state of osteoclasts. During bone resorption, osteoclasts transport H ϩ into the resorption lacuna through vacuolar H ϩ pumps located in the ruffled border membrane (35) . Because this H ϩ pump is electrogenic (9), countermovement of appropriate ions is required to maintain the activity of the H ϩ transport at a constant level and to prevent the accumulation of electric charges (3). Thus Cl Ϫ channels act as a charge transport pathway for electrical neutralization against the charge accumulation associated with the H ϩ transport. For example, the Cl Ϫ channel blocker DIDS inhibits bone resorption (11, 18) . Also, disruption of the CLC-7 Cl Ϫ channel in mice leads to severe osteopetrosis that is due to (17, 27 ). Our results demonstrate that the PGE 2 -induced depolarization in osteoclasts is due to activation of outwardly rectifying Cl Ϫ channels.
In many cell types including osteoclasts, it has been suggested that Cl Ϫ channels also contribute to cell volume regulation and that their activation leads to the loss of cytoplasmic osmolytes and water, resulting in a cell volume decrease (28, 31) . The physiological consequences of this effect for osteoclast function and bone resorption remain to be investigated.
Electrophysiological and morphological analyses of PGE 2 actions were performed with HEPES-buffered (or in some experiments bicarbonate buffered) solutions. We found a good correlation between electrophysiological and morphological changes induced by PGE 2 regarding time course, reversibility, and cAMP dependence. These results suggest a correspondence between electrophysiological and morphological effects of PGE 2 . Qualitatively similar results were also observed in our experiments using bicarbonate-buffered solutions, indicating that the electrophysiological and morphological changes induced by PGE 2 are of physiological significance.
It is likely that activation of the Cl Ϫ channel by PGE 2 will lower [Ca 2ϩ ] i levels by depolarizing the membrane potential of bulgy, serrated osteoclasts and thereby reduce osteoclast motility as observed in this study. Because there is a good correlation between osteoclast motility and bone-resorbing activity (40) , suppression of osteoclast motility by PGE 2 via EP2 receptor activation is likely to reduce bone resorption.
